HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a study-Reference-Cited by-同舟云学术

HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a study

Published:2024-06-27 Issue:1 Volume:13 Page:
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Yang Tao¹^ORCID,Xie Zhiman²,Xu Zhe¹,Tu Bo¹,Lu Huan²,Huang Huihuang¹,Huang Lei¹,Zhang Chao¹^ORCID,Gao Liying³,Jin Lei¹,Ma Ping³,Zou Jun²,Liu Limin¹,Zhen Cheng¹,Zhou Chunbao¹,Meng Sirun²,Li Yuan-Yuan¹,Song Jin-Wen¹,Yang Shixiong²,Ai Hui-Sheng⁴,Jiao Yanmei¹^ORCID,Shi Ming¹^ORCID,Xu Ruonan¹,Wang Fu-Sheng¹^ORCID

Affiliation:

1. Senior Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, People’s Republic of China

2. Infectious Diseases Department, The Fourth People’s Hospital of Nanning, Nanning, People’s Republic of China

3. Department of Infectious Diseases, Tianjin Second People’s Hospital, Tianjin, People’s Republic of China

4. Senior Department of Hematology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, People’s Republic of China

Funder

National Key Laboratory of Aerodynamic Design and Research

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2024.2364744

Reference45 articles.

1. Predictors of Survival in HIV-Infected Persons With 50 or Fewer CD4 Cells/mm3

2. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

3. Immune restoration in HIV-1-infected patients after 12 years of antiretroviral therapy: a real-world observational study

4. Chinese guidelines for the diagnosis and treatment of HIV/AIDS (2021 edition);AIDS and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association; Chinese Center for Disease Control and Prevention;Infectious Diseases & Immunity,2022

5. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity